Partner Headlines - BCRX

  1. US Stock Futures Signal Higher Start On Wall Street

    Benzinga
  2. Market Mixed Amid Plan To Spend $300 Million On Ebola Vaccines

    Benzinga
  3. UPDATE: Bank Of America Reiterates On BioCryst Pharmaceuticals ...

    Benzinga
  4. Ebola Vaccine Contenders

    Benzinga
  5. Making Money With Charles Payne: 10/24/14

    FoxBusiness
  6. Stomach-Churning Ride for Ebola Stocks

    FoxBusiness
  7. Sarepta Therapeutics Shares Up On Ebola Drug Safety Study

    Benzinga
  8. Making Money With Charles Payne: 10/16/14

    FoxBusiness
  9. Making Money With Charles Payne: 10/08/14

    FoxBusiness
  10. Ebola Patient Eric Duncan Dies; Related Stocks Fall On News

    Benzinga
  11. US Stock Futures Edge Higher Ahead Of Alcoa Earnings, Fed Minutes

    Benzinga
  12. Making Money With Charles Payne: 10/07/14

    FoxBusiness
  13. Benzinga's Top #PreMarket Gainers

    Benzinga
  14. BioCryst Reports Late Breaker Presentation of OPuS-1 Phase 2 ...

    Benzinga
  15. Making Money With Charles Payne: 10/0614

    FoxBusiness
  16. Chimerix Ebola Drug OK'd; Tekmira Drops On Downgrade

    IBD
  17. Ebola Sector Shake Out Leaves Chimerix Inc On Top

    Benzinga
  18. U.S. Stocks Turn Red; CareFusion Shares Surge On Announcement ...

    Benzinga
  19. Markets Open Higher; Hewlett-Packard Plans To Split Into Two ...

    Benzinga
  20. Jobs Data Boost Stock Futures; Salix, Tekmira, Iamgold Rising

    IBD
  21. Making Money With Charles Payne: 10/01/14

    FoxBusiness
  22. Ebola-Related Pharma Stocks Soar On First U.S. Case

    IBD
  23. Morning Market Movers

    Benzinga
  24. Making Money With Charles Payne: 09/30/14

    FoxBusiness
  25. Dow Jumps 170 Points; Bed Bath & Beyond Shares Rise On Upbeat ...

    Benzinga
  26. U.S. Stocks Rise; Accenture Shares Decline On Weak Forecast

    Benzinga
  27. BioCryst Receives Additional NIAID Funding For Manufacture and ...

    Benzinga
  28. Momentum Stocks Showing Weakness

    Benzinga
  29. BioCryst Announces RAPIVAB Trial Results For The Treatment Of ...

    Benzinga
  30. BioCryst Pharmaceuticals, Inc. Sinks; WHO Notes Ebola Safety ...

    Benzinga
  31. BioCryst To Present Peramivir Trial Results For The Treatment ...

    Benzinga
  32. US Stock Futures Gain Ahead Of Consumer Data

    Benzinga
  33. Biotechs That Might Benefit From Ebola

    Benzinga
  34. Benzinga's Top #PreMarket Gainers

    Benzinga
  35. Stocks Hitting 52-Week Highs

    Benzinga
  36. Benzinga's Top Initiations

    Benzinga
  37. JP Morgan Initiates BioCryst Pharmaceuticals At Overweight

    Benzinga
  38. MLV & Co Sees Positive Momentum Going Into 2H14 For BioCryst ...

    Benzinga
  39. Ebola Stocks Continue Higher

    Benzinga
  40. UPDATE: Wells Fargo Upgrades BioCryst

    Benzinga
  41. UPDATE: H.C. Wainwright & Co. Initiates Coverage on BioCryst ...

    Benzinga
  42. Benzinga's Top Initiations

    Benzinga
  43. Morning Movers for Feb. 25, 2014: IMUC, MSO, ZU, CARA, VSI, TSLA, ...

    Benzinga
  44. Benzinga's Top #PreMarket Gainers

    Benzinga
  45. Benzinga's Top Downgrades

    Benzinga
  46. Benzinga's Top Initiations

    Benzinga
  47. UPDATE: JMP Securities Places BioCryst Pharmaceuticals PT Under ...

    Benzinga
  48. US Stock Futures Gain Ahead Of GDP Data

    Benzinga
  49. BioCryst Files Peramivir NDA for Influenza

    Benzinga
  50. Benzinga's Top #PreMarket Gainers

    Benzinga
  51. BioCryst Selects Two Plasma Kallikrein Inhibitors for Hereditary ...

    Benzinga
  52. BioCryst Initiates Phase 2a Clinical Trial of BCX4161 in Patients ...

    Benzinga
  53. Benzinga's Top Pre-Market Gainers

    Benzinga
  54. BioCryst Awarded Up to $22M Contract by the NIAID to Develop ...

    Benzinga
  55. JMP Calls BioCryst's Oral Kallikrein 'Potential Game Changer,' ...

    Benzinga
  56. UPDATE: JMP Securities Raises PT on BioCryst Pharmaceuticals ...

    Benzinga
  57. Benzinga's Top Pre-Market Gainers

    Benzinga
  58. FDA Removes Clinical Hold on BioCryst's BCX 4161 -8K

    Benzinga
  59. Benzinga's Top Pre-Market Gainers

    Benzinga
  60. BioCryst Prices 4M Share Offering at $4.40/Share

    Benzinga
  61. UPDATE: Bank of America Downgrades BioCryst Pharmaceuticals on ...

    Benzinga
  62. Benzinga's Top Pre-Market Losers

    Benzinga
  63. UPDATE: Bank of America Resumes Coverage on BioCryst Pharmaceuticals ...

    Benzinga
  64. Benzinga's Small Cap Movers for Wednesday January 2, 2013

    Benzinga
  65. Ballots Are In: Worst CEO in the Biotech Industry Is . . .

    YCharts
  66. BioCryst Pharmaceuticals, Presidio Pharmaceuticals Terminate ...

    Benzinga
  67. BioCryst Broad-Spectrum Antiviral BCX4430 Shows Effective and ...

    Benzinga
  68. BioCryst Pharmaceuticals Inc. Reports Operating Results (10-Q)

    GuruFocus
  69. BioCryst Announces Withdrawal of BCX5191 Investigational New ...

    Benzinga
  70. Benzinga's M&A Chatter for Thursday October 18, 2012

    Benzinga
  71. BioCryst Pharmaceuticals and Presidio Pharmaceuticals to Merge

    Benzinga
  72. BioCryst Pharmaceuticals, Presidio Pharmaceuticals to Merge

    Benzinga
  73. BioCryst Pharmaceuticals Inc. Reports Operating Results (10-Q)

    GuruFocus
  74. A Peek Into The Market Before The Trading Starts

    Benzinga
  75. IHS, Ebix Included in Stocks Up on High Volume Friday

    FoxBusiness
  76. Swine Flu Has BioPharma as Happy as Pigs in Filth

    Benzinga
  77. Swine Flu Has BioPharma as Happy as Pigs in Filth

    Benzinga
  78. Swine Flu Outbreak in Mexico Sends Small BioPharma Sky-High

    Benzinga
  79. Benzinga's Microcap Movers for Thursday January 12, 2012

    Benzinga
  80. Oink Oink: Profit From The Return Of Swine Flu

    Benzinga
  81. UPDATE: Bank of America Meets with BioCryst Pharma Management ...

    Benzinga
  82. Bank of America Comments on BCRX Phase-3 Data

    Benzinga
  83. BoardCentral StockTalk - weekly update: AAPL, F, MSFT, KERX, ...

    BoardCentral
Trading Center